Board of Directors
Our Board of Directors is composed of accomplished industry leaders with extensive experience in healthcare, pharmaceuticals, corporate and business development, and finance who are passionate about improving patients’ lives.
Xeris Pharmaceuticals, Chairman and CEO
Domain Associates, Managing Director
Milestone Pharmaceuticals, President and Chief Executive Officer
CRISPR Therapeutics, Chief Financial Officer
LQT Therapeutics Inc., Chief Executive Officer
Weill Cornell Medical College, Clinical Professor